|
|
||||||||
a Center for Aortic Surgery, Marfan Syndrome and Connective Tissue Disorders Clinic, and Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
b Medical City Hospital, Dallas, Texas
c Columbia Presbyterian Medical Center, New York, New York
d Consultant, Lake Forest, California
Accepted for publication April 9, 2008.
* Address correspondence to Dr Svensson, Center for Aortic Surgery, Marfan and Connective Tissue Disorder Clinic, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, 9500 Euclid Avenue, Desk F25, Cleveland, OH 44195 (Email: svenssl{at}ccf.org).
Presented at the Forty-fourth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 28–30, 2008.
Background: Recent US and European registries have indicated 30% to 60% of patients with critical valvular aortic stenosis (AS) are not treated surgically, usually due to advanced age and comorbidities. We report on a Food and Drug Administration approved feasibility study of a less invasive transcatheter approach to potentially treat these high-risk patients.
Methods: Between December 2006 and February 18, 2008, 40 patients underwent transcatheter insertion of a balloon expandable stainless-steel stent with an internally mounted three-leaflet equine pericardial valve (Edwards Sapien Transcatheter Heart Valve; Edwards Lifesciences, Irvine, CA) into the aortic annulus using a transapical left ventricular insertion (TA-AVI). Patients were inoperable by conventional surgery, or extremely high risk based on Society of Thoracic Surgeons score greater than 15% or other documented risk factors.
Results: All 40 valves were successfully delivered and 35 were successfully seated. Two valves embolized and required open aortic valve replacement (AVR), and one case of severe regurgitation later required AVR. In a further two patients placed on cardiopulmonary support, one valve later embolized and one migrated. There were 7 (17.5%) deaths within 30 days, and a further 2 (5%) deaths before discharge at 42 and 72 days. There were no immediate postoperative strokes after successful deployment. Valve area improved from 0.62 cm2 (SD of 0.13) to 1.61 cm2 (SD 0.37) at 30 days (p = <0.0001), with mean perivalvular regurgitation of 1.19 (SD 0.80). Mean follow-up was 143 days (SD 166 days) with 6 further deaths from comorbid disease, none valve or cardiac related. The Kaplan-Meier survival was 81.8% ± 6.2% at 1 month and 71.7% ± 7.7% at 3 months.
Conclusions: Transapical insertion of a balloon expandable stented valve is feasible but carries considerable risk and will be further evaluated in the PARTNER (Placement of AoRTic traNscathetER valve) randomized trial.
This article has been cited by other articles:
![]() |
A. N. Azadani, N. Jaussaud, P. B. Matthews, L. Ge, T. S. Guy, T. A.M. Chuter, and E. E. Tseng Energy Loss Due to Paravalvular Leak With Transcatheter Aortic Valve Implantation Ann. Thorac. Surg., December 1, 2009; 88(6): 1857 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Klein, S. T. Webb, S. Tsui, C. Sudarshan, L. Shapiro, and C. Densem Transcatheter aortic valve insertion: anaesthetic implications of emerging new technology Br. J. Anaesth., December 1, 2009; 103(6): 792 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-P. Kappetein, N. Piazza, J.-C. Laborde, P. P. de Jaegere, and P. W. Serruys Transapical implantation of a self-expanding aortic valve bioprosthesis -- animal feasibility study Eur. J. Cardiothorac. Surg., November 1, 2009; 36(5): 813 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bleiziffer, H. Ruge, D. Mazzitelli, A. Hutter, A. Opitz, R. Bauernschmitt, and R. Lange Survival after transapical and transfemoral aortic valve implantation: Talking about two different patient populations J. Thorac. Cardiovasc. Surg., November 1, 2009; 138(5): 1073 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Masson, J. Kovac, G. Schuler, J. Ye, A. Cheung, S. Kapadia, M. E. Tuzcu, S. Kodali, M. B. Leon, and J. G. Webb Transcatheter Aortic Valve Implantation: Review of the Nature, Management, and Avoidance of Procedural Complications J. Am. Coll. Cardiol. Intv., September 1, 2009; 2(9): 811 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walther, V. Falk, M. A. Borger, J. Kempfert, J. Ender, A. Linke, G. Schuler, and F. W. Mohr Transapical aortic valve implantation in patients requiring redo surgery Eur. J. Cardiothorac. Surg., August 1, 2009; 36(2): 231 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Salizzoni, P. Bajona, K. J. Zehr, W. D. Anderson, S. Vandenberghe, and G. Speziali Transapical off-pump removal of the native aortic valve: a proof-of-concept animal study. J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 468 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gasparovic Prosthesis-patient mismatch in the elderly. Ann. Thorac. Surg., August 1, 2009; 88(2): 709 - 710. [Full Text] [PDF] |
||||
![]() |
D. Himbert, F. Descoutures, N. Al-Attar, B. Iung, G. Ducrocq, D. Detaint, E. Brochet, D. Messika-Zeitoun, F. Francis, H. Ibrahim, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J. Am. Coll. Cardiol., July 21, 2009; 54(4): 303 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Al-Attar, W. Ghodbane, D. Himbert, C. Rau, R. Raffoul, D. Messika-Zeitoun, E. Brochet, A. Vahanian, and P. Nataf Unexpected complications of transapical aortic valve implantation. Ann. Thorac. Surg., July 1, 2009; 88(1): 90 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Aregger, P. Wenaweser, G. J. Hellige, A. Kadner, T. Carrel, S. Windecker, and F. J. Frey Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2175 - 2179. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Adams, A. C. Anyanwu, J. Chikwe, and F. Filsoufi The Year in Cardiovascular Surgery J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2389 - 2403. [Full Text] [PDF] |
||||
![]() |
J. G. Webb, L. Altwegg, R. H. Boone, A. Cheung, J. Ye, S. Lichtenstein, M. Lee, J. B. Masson, C. Thompson, R. Moss, et al. Transcatheter Aortic Valve Implantation: Impact on Clinical and Valve-Related Outcomes Circulation, June 16, 2009; 119(23): 3009 - 3016. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zajarias and A. G. Cribier Outcomes and Safety of Percutaneous Aortic Valve Replacement J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1829 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Clavel, J. G. Webb, P. Pibarot, L. Altwegg, E. Dumont, C. Thompson, R. De Larochelliere, D. Doyle, J.-B. Masson, S. Bergeron, et al. Comparison of the Hemodynamic Performance of Percutaneous and Surgical Bioprostheses for the Treatment of Severe Aortic Stenosis J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1883 - 1891. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola The Year in Valvular Heart Disease J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1894 - 1908. [Full Text] [PDF] |
||||
![]() |
V. Kurra, P. Schoenhagen, E. E. Roselli, S. R. Kapadia, E. M. Tuzcu, R. Greenberg, M. Akhtar, M. Y. Desai, S. D. Flamm, S. S. Halliburton, et al. Prevalence of significant peripheral artery disease in patients evaluated for percutaneous aortic valve insertion: Preprocedural assessment with multidetector computed tomography. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1258 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. T. Billings IV, S. K. Kodali, and J. S. Shanewise Transcatheter Aortic Valve Implantation: Anesthetic Considerations Anesth. Analg., May 1, 2009; 108(5): 1453 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bleiziffer, H. Ruge, D. Mazzitelli, C. Schreiber, A. Hutter, J.-C. Laborde, R. Bauernschmitt, and R. Lange Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 615 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bajona Hybrid Cardiac Surgery: A Resident's Perspective Arch Surg, March 1, 2009; 144(3): 207 - 208. [Full Text] [PDF] |
||||
![]() |
A. Vahanian, B. Iung, L. Piérard, R. Dion, and J. Pepper CHAPTER 21 Valvular Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Herrmann Transcatheter Aortic Valve Implantation: Past, Present, and Future Circ Cardiovasc Interv, December 1, 2008; 1(3): 159 - 160. [Full Text] [PDF] |
||||
![]() |
L. G. SVENSSON Evolution and results of aortic valve surgery, and a 'disruptive' technology Cleveland Clinic Journal of Medicine, November 1, 2008; 75(11): 802 - 804. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |